← Back to news
NewsCLINICAL PHARMACOLOGY AND THERAPEUTICSSaturday, February 7, 2026 · February 7, 2026

Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.

WHY IT MATTERS

Recent peer-reviewed research on Pulmonary arterial hypertension associated with another disease that may be relevant for patients and caregivers.

Antibody-drug conjugates are proving to be highly effective in oncology, yet their real-world respiratory safety profile remains largely unknown. This study sought to characterize drug-linked respiratory disorders and identify safety signals. We performed a descriptive analysis with expert review of...

Read on PubMed
Read the original at Clinical pharmacology and therapeutics
ResearchPubMedPulmonary arterial hypertension associated with another diseaseHumansPharmacovigilance

Related conditions

Pulmonary arterial hypertension associated with another disease

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.